Important Notice for Applied Therapeutics Investors
Attention all shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). This notice serves as a crucial update regarding the ongoing class action lawsuit that could impact your investments.
Class Action Participation Details
If you acquired shares of APLT during the specified class period, it is essential to reach out for potential lead plaintiff designation. The opportunity to serve as a lead plaintiff does not limit your eligibility for any recovery associated with this case.
Chronology of Allegations
The allegations surrounding this class action stem from significant announcements made by Applied Therapeutics. On a date in late November, the company disclosed that it had received a Complete Response Letter (CRL) from the FDA regarding its New Drug Application (NDA) for govorestat, its lead drug candidate. The FDA's review concluded that the application could not be approved in its current state due to critical deficiencies.
This news caused a substantial drop in the stock price of Applied Therapeutics. On the last market day before the announcement, the stock closed at approximately $10.21, only to plummet dramatically following the disclosure. Within a few days, it experienced a staggering decline, dropping to $1.75, marking an over 80% decrease in value. Further distress was brought upon investors when a warning letter from the FDA about clinical trial issues was revealed shortly thereafter. Each day brought new lows, leading to a significant loss for affected shareholders.
Deadline and Next Steps for Shareholders
The deadline for shareholders to register concerning this class action lawsuit is on a specified date soon approaching. It's important not to delay your registration. Once registered, you will gain access to a system designed to keep you informed about the case's developments.
It's essential to acknowledge that there is no financial obligation on your part to partake in this action. Enrollment in this monitoring system will provide you with important insights throughout the legal proceedings.
Why Choose Gross Law Firm?
The Gross Law Firm has established itself as a leading firm advocating for the rights of investors nationwide. Their commitment lies in safeguarding shareholders from deception and unlawful business practices. Their core mission is to ensure accountability among businesses and protect investors from financial losses incurred from misleading statements or omissions.
With a reputation for standing up against corporate missteps, they strive to restore investor confidence and seek justice for those affected.
Contact Information for Further Inquiries
If you have any questions or require assistance, feel free to reach out directly.
Contact:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY 10018
Phone: (646) 453-8903
Frequently Asked Questions
What should APLT shareholders do?
Shareholders are encouraged to register for the class action lawsuit before the deadline.
What are the main allegations against Applied Therapeutics?
The company faced allegations following a critical FDA response that led to a dramatic stock price drop.
Is it necessary to be a lead plaintiff to recover losses?
No, being a lead plaintiff is not a requirement to participate in potential recovery.
What is the role of The Gross Law Firm?
They represent investors and advocate for their rights against corporate misconduct.
How can investors stay updated on their case status?
Registered shareholders will receive ongoing updates through a monitoring system set by the firm.
